Moran Sean F.
SEC insider (Form 3/4/5 filer). CIK 0001451495. Chief Financial Officer at Corbus Pharmaceuticals Holdings, Inc. (CRBP). 7 reported Form 4/5 transactions since Sep 2024; latest on Aug 7, 2026. Located in NORWOOD, MA.
Companies Moran Sean F. has filed insider reports for
- Corbus Pharmaceuticals Holdings, Inc. (CRBP): Officer, Chief Financial Officer
Moran Sean F.
CIK: 0001451495
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Corbus Pharmaceuticals Holdings, Inc.
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Aug 7, 2026CRBP
Corbus Pharmaceuticals Holdings, Inc.
SaleDirect12K shares at avg. $10.08$121K - Feb 13, 2026CRBP
Corbus Pharmaceuticals Holdings, Inc.
SaleDirect4.7K shares at avg. $7.78$37K - Jan 14, 2026CRBP
Corbus Pharmaceuticals Holdings, Inc.
AwardDirect28.1K shares- - Oct 24, 2025CRBP
Corbus Pharmaceuticals Holdings, Inc.
SaleDirect13K shares at avg. $17.02$221K - Oct 24, 2025CRBP
Corbus Pharmaceuticals Holdings, Inc.
ExerciseDirect13K shares at avg. $4.26$55K - Feb 14, 2025CRBP
Corbus Pharmaceuticals Holdings, Inc.
SaleDirect2.8K shares at avg. $8.76$24K - Jan 31, 2025CRBP
Corbus Pharmaceuticals Holdings, Inc.
AwardDirect27.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 7, 2026 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale | 12,000 | $10.08 | $120,971 | Direct |
| Feb 13, 2026 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale | 4,701 | $7.78 | $36,588 | Direct |
| Jan 14, 2026 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Award | 28,082 | - | $0 | Direct |
| Oct 24, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale | 12,981 | $17.02 | $220,937 | Direct |
| Oct 24, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Exercise | 12,981 | $4.26 | $55,299 | Direct |
| Feb 14, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale | 2,792 | $8.76 | $24,446 | Direct |
| Jan 31, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Award | 27,500 | - | - | Direct |
1-7 of 7 transactions